The efficacy of low-molecular-weight heparin as a prophylactic agent was A single injection of low-molecular-weight heparin daily is a convenient way of preventing deep vein thrombosis in high-risk patients undergoing major abdominal surgery.
Introduction
The anticoagulant action of heparin results from its ability to bind and activate antithrombin III, a heparin cofactor. Antithrombin III inhibits several activated coagulation factors in addition to thrombin, including factors IXa, Xa, XIa, and XIIa; all these inhibition reactions are greatly accelerated in the presence of heparin.'-5 Commercially available heparin consists of components with molecular weights ranging from 3000 to 40 000 daltons and an average of about 15 000.6 7 Studies on heparin fractions of different molecular weights obtained by gel filtration have shown a molecular-size-dependency of the anticoagulant activity. 4-12 The potentiation of the inhibition of factor Xa in plasma system increases with decreasing molecular weight.8-10 In contrast, measurements by multiple-role clotting assay such as the activated partial thromboplastin time (APTT) decrease with decreasing molecular weight.'0-"3
We investigated whether low-molecular-weight and unfractionated heparin affect the coagulation mechanism to the same extent in patients undergoing major abdominal surgery, and whether low-molecular-weight heparin prevents postoperative deep vein thrombosis without producing excessive bleeding.
Patients and methods
One hundred and eighty patients undergoing major abdominal surgery were investigated. All received a written and oral description of the study protocol and gave their consent to participate.
Heparin-Unfractionated heparin was commercial heparin calcium (Calciparine); to prepare low-molecular-weight fraction, it was extracted with a mixture of ethanol and water'4 and purified. The fraction was studied by physical ("3C-nuclear magnetic resonance spectroscopy) and chemical techniques. Compared with unfractionated heparin, the low-molecular-weight fraction contained a higher percentage of non-sulphated uronic acid-particularly glucuronic acid (about 30% to total uronic acids)-as well as a higher percentage of N-acetyl-glucosamine, whereas the content in sulphate groups was lower (J Choay, personal communication). The molecular weights of unfractionated heparin and the low-molecular-weight fraction were estimated by comparing their elution positions from a column of Ultrogel with the fractions whose molecular weights had been determined by a sedimentation diffusion equilibrium method. The mean molecular weight of unfractionated heparin was 16 000 daltons and of low-molecular-weight heparin 6000 daltons. The anticoagulant activities of the two heparin preparations were assessed using APTT'5 and anti-factor Xa clotting assays.!' The low-molecular-weight fraction had a specific activity of 200 U/mg in anti-factor Xa assay and 50 U/mg in APTT assay. The ratio between both types of activities in tests using human plasma was thus 4. Unfractionated heparin had a specific activity of 150 U/mg in both assays. The low-molecularweight fraction was supplied in a single-dose phial prepared under approved pharmaceutical conditions and containing either 1250 APTT units (5000 anti-factor Xa units) in 0-2 ml or 1850 APTT units (7500 anti-Xa units) in 0 3 ml. Results of tests for sterility and pyrogens were satisfactory.
Effect on coagulation mechanism-Thirty patients were allocated at random to receive 5000 anti-factor Xa units of low-molecular-weight or unfractionated heparin subcutaneously, starting two hours before surgery and then every 12 hours for seven days afterwards. Blood samples were obtained before administration of heparin, before surgery in the anaesthetic room, midway during operation, in the recovery room, and on the first and seventh postoperative days. They were analysed for heparin concentrations measured by anti-factor Xa Platelet function tests A 5-ml sample of blood was collected with a 19-G bore needle using clean venepuncture without stasis, and onehalf volume aliquots were placed in ice tubes containing edetic acid and theophylline and the other half in similar tubes containing edetic acid theophylline, and freshly prepared indomethacin 55 mmol (2 mg/100 ml) to reduce artefactual production of thromboxane B2. These tubes were kept in ice and centrifuged within 30 minutes at (table III) There was no significant difference in the mean APTT after administration of two preparations of heparin in the samples withdrawn in the anaesthetic room, during surgery, in the recovery room, and on the first and seventh postoperative days. Heparin concentrations measured by an anti-factor Xa assay showed a different response in the two groups; the mean concentration in the sample withdrawn during surgery was 0-175 ± SEM 0-02 U/ml in the group who received low-molecular-weight heparin and 0-09±0 03 U/ml in the group receiving unfractionated heparin; this difference was statistically significant (p <0 05). The mean concentration of antithrombin III before surgery was 99-5% of the normal in the patients who received low-molecular-weight heparin; a significant fall was observed during and after surgery. Similar changes were also seen in patients who received unfractionated heparin.
Prekallikrein, lipoprotein lipase, and fibrinopeptide A (table IV)-A significant difference in plasma prekallikrein concentration was observed on the first and seventh postoperative days compared with the preoperative value in the patients who received unfractionated heparin; the preoperative value was 64-3 ±SEM 6 2% of the normal and this fell to 37 4 ± 8 3%h on the first and 32 0 ±4-6% on the seventh postoperative days (p < 0 01). The plasma prekallikrein concentration remained raised throughout the observation period in the group receiving low-molecular-weight heparin (table IV) . Both lowmolecular-weight and unfractionated heparin caused a significant increase in lipoprotein lipase activity, the raised activities subsequently persisted throughout the period of observation (table IV). The increase was even greater in those who received unfractionated heparin. The difference in the lipoprotein lipase release in the two groups was statistically significant (p < 0-05). A significant increase in the concentrations of fibrinopeptide A was also observed during and after surgery in both groups, but the difference between the two groups was not significant (table IV). 13-thromboglobulin, platelet factor 4, thromboxane B2 concentrations, and bleeding time (table V)-As the results of platelet-function tests were not normally distributed non-parametric statistics in the form of a Mann-Whitney two-tail test was used to analyse the data obtained. An increase in the concentrations of 3-thromboglobulin and platelet factor 4 was observed during surgery in both groups, but the differences, when compared with the preoperative values or intragroup values, were not significant. In the group receiving unfractionated heparin the median concentrations of thromboxane B2 increased from 110 ng/l before surgery to 300 ng/l during operation, this difference being statistically significant (p <002). Raised concentrations were also observed in the samples withdrawn in the recovery room. Figure  1 shows Simplate bleeding time in 25 patients who received a single injection of 1850 APTT units of low-molecular-weight heparin. The difference between the mean Simplate bleeding time before, during, and 24 hours after surgery was not statistically significant, though a rise greater than 1 SD was observed in six patients. In seven patients the bleeding time was reduced to below 1 SD, five of these being operated on for malignant disease. The mean plasma heparin concentration during surgery was 0-28 U/ml, the range being 0 08 to 0-6 U/ml. Increases in the Simplate bleeding time were unrelated to changes in the plasma heparin concentration. In nine of 25 patients, circulating heparin could still be detected 24 hours after a single subcutaneous injection (fig 2) .
Prevention of deep vein thrombosis-Of 150 consecutive patients investigated, the first 50 received 1250 APTT units of the lowmolecular-weight heparin every 12 hours while the other 100 patients received a single injection of 1850 APTT units of low-molecularweight heparin daily during the first seven days after operation. Isotopic deep vein thrombosis was diagnosed in three of the 50 patients receiving two injections daily; phlebography confirmed the presence of thrombi in only two cases, and in each instance, thrombi were confined to calf veins only. Thrombi were detected on the seventh, 11th, and 15th postoperative days. Twelve out of 50 patients were operated on for malignant disease, and none of these developed deep vein thrombosis. None of these patients developed symptoms or signs of minor pulmonary embolism, and none died during the postoperative period. Isotopic deep vein thrombosis was detected in three of 100 patients receiving one injection of low-molecular-weight -p 0-05;-compared w.ith value before operation. heparin daily. Thrombi were detected on the second, fourth, and sixth postoperative days and the raised counts persisted for 48 to 72 hours only. Phlebography failed to confirm the presence of thrombi in each instance. Three patients died during the postoperative period and necropsy was performed in each case: one patient died on the ninth postoperative day owing to Gram-negative septicaemia after the resection of carcinoma of the sigmoid colon; the other two patients died from advanced carcinomatosis secondary to carcinoma of stomach, one on the 14th and the other on the 19th day after operation. Both patients had palliative gastrojejenostomy. No pulmonary emboli or thrombi in the deep veins were found at necropsy.
Operative and postoperative bleeding-Prophylaxis was discontinued in two patients who received low-molecular-weight heparin every 12 hours; one developed extensive bruising at the site of injection and the other had excessive blood loss at the time of surgery. Two of 100 patients who received a single daily injection developed wound haematoma; one after an anterior resection and the other after abdominoperineal resection of the rectum. There was no statistically significant difference in the amount of blood transfused in both groups or in the fall in the postoperative haemoglobin concentration in the two groups, either when analysed on the basis of different operations or in the groups as a whole (table VI). found to decrease with decreasing molecular weight. Inactivation of factor Xa, factor XIIa, and kallikrein was potentiated by lowmolecular-weight heparin fractions that had virtually no effect on the inhibition of thrombin or factors IXa and XIa. This suggests that the antithrombotic properties of low-molecularweight heparin may be related to its ability to potentiate inactivation of serine proteinases in the initial stages of the coagulation cascade.29 Thus low-molecular-weight heparin would possess antithrombotic properties with little effect on the clotting time and, possibly, without causing bleeding. Our second aim was to determine the efficacy of low-molecularweight heparin as a prophylactic agent against venous thromboembolism. Isotopic deep vein thrombosis was diagnosed in three of 50 patients who received two injections of 1250 units of lowmolecular-weight heparin per day. In three out of 100 patients who received a single daily injection of 1850 units of the lowmolecular-weight fraction raised counts were detected but phlebography failed to confirm the presence of thrombi in each instance. The most likely explanation for this discrepancy is that small thrombi detected by the 125I fibrinogen uptake test in the muscular veins of the calf may not be shown by phlebography which often fails to visualise such veins.
None of the 150 patients who received low-molecular-weight heparin died from fatal or contributory pulmonary emboli. The other advantage of using low-molecular-weight heparin is the reduced frequency of bleeding complications after operation. Prophylaxis was discontinued owing to bleeding complications in two of 50 patients who received injections every 12 hours and in none of 100 patients receiving one daily injection. Three patients developed wound haematoma; two had received lowmolecular-weight heparin every 12 hours, while the third belonged to the group who received one injection daily.
One of the disadvantages of the low-dose heparin prophylaxis is that the drug has to be administered every eight or 12 hours, so requires considerable nursing time. A single injection of lowmolecular-weight heparin every day would not only reduce the frequency of haemorrhagic side effects but would also overcome the need for frequent drug administration and thus lead to better acceptance by the patients. MEDICINES TEMPERATE-If the world be composed of extremes, then it acts by extremes, for as the man is, so is his work: therefore it is impossible that any medicine can be temperate, but may be reduced to heat, cold, dryness, or moisture, and must operate (I mean such as operate by manifest quality) by one of these, because there is no other to operate by, and that there should be such a temperate mixture, so exquisitely of these qualities in any medicine, that one of them should not manifestly excel the other, I doubt it is a system too rare to find. Thus then I conclude the matter to be, those Medicines are called temperate (not because they have excess of temperature at all in them) which can neither be said, to heat nor cool so much as will amount to the first degree of excess, for daily experience witnesses that they being added to medicines, change not their qualities, they make them neither hotter nor colder.
They are used in such diseases where there is no manifest distemper of the first qualities, viz heat and cold, for example; In obstruction of the bowels, where cold medicines might make the obstruction greater, and hot medicines cause a fever. In fevers of flegm, where the cause is cold and moist, and the effect hot and dry; in such, use temperate medicines which may neither encrease the fever by their heat, nor condensate the flegm by their coldness. Besides, because contraries are taken away by their contraries, and every like maintained by its like, they are of great use, to preserve the constitution of the body temperate, and the body itself in strength and vigour, and may be used without danger, or fear of danger, by considering which part of the body is weak, and using such temperate medicines as are appropriated to that part. (Nicholas Culpeper (1616-54) The Complete Herbal, 1850.)
